CERAVE DEVELOPED WITH DERMATOLOGISTS BHA EXFOLIATING TONER ACNE TREATMENT- salicylic acid liquid

Drug Labeling and Warnings

Drug Details [pdf]

Active ingredient

Salicylic acid 2%

Purpose

Acne treatment

Uses

• for the treatment of acne
• clears acne blemishes and blackheads and allows skin to heal
• helps prevent new acne blemishes and blackheads from forming

Warnings

For external use only

When using this product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• clean the skin thoroughly before applying this product
• cover the entire affected area with a thin layer one to three times daily, applying a dime-sized amount on a cotton pad
• because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
• if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Inactive ingredients

water, pentylene glycol, triethyl citrate, butylene glycol, glycerin, ceramide NP, ceramide AP, ceramide EOP, carbomer, glycolipids, niacinamide, sodium hydroxide, sodium citrate, sodium benzoate, sodium lauroyl lactylate, sodium phosphate, cholesterol, disodium phosphate, hydroxyethylcellulose, capryloyl salicylic acid, tetrasodium glutamate diacetate, caprylyl glycol, phytosphingosine, xanthan gum, polysorbate 60, benzoic acid

Questions or comments?

Toll-free number 1-888-768-2915

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

CERAVE DEVELOPED WITH DERMATOLOGISTS BHA EXFOLIATING TONER ACNE TREATMENT 
salicylic acid liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 82046-291
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	20 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
PENTYLENE GLYCOL (UNII: 50C1307PZG)
TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
GLYCERIN (UNII: PDC6A3C0OX)
CERAMIDE NP (UNII: 4370DF050B)
CERAMIDE AP (UNII: F1X8L2B00J)
CARBOMER (UNII: 0A5MM307FC)
NIACINAMIDE (UNII: 25X51I8RD4)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
SODIUM CITRATE (UNII: 1Q73Q2JULR)
SODIUM BENZOATE (UNII: OJ245FE5EU)
SODIUM LAUROYL LACTYLATE (UNII: 7243K85WFO)
SODIUM PHOSPHATE (UNII: SE337SVY37)
CHOLESTEROL (UNII: 97C5T2UQ7J)
DISODIUM PHOSPHATE (UNII: 22ADO53M6F)
HYDROXYETHYLCELLULOSE (UNII: T4V6TWG28D)
CAPRYLOYL SALICYLIC ACID (UNII: 5F7PJF6AA4)
TETRASODIUM GLUTAMATE DIACETATE (UNII: 5EHL50I4MY)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)
XANTHAN GUM (UNII: TTV12P4NEE)
POLYSORBATE 60 (UNII: CAL22UVI4M)
BENZOIC ACID (UNII: 8SKN0B0MIM)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 82046-291-01	237 mL in 1 BOTTLE; Type 0: Not a Combination Product	05/19/2026

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	05/19/2026

Labeler - L'Oreal USA Products Inc (002136794)

Establishment
Name	Address	ID/FEI	Business Operations
L'Oreal USA Products, Inc.		624244349	manufacture(82046-291)

Establishment
Name	Address	ID/FEI	Business Operations
Unette Corporation		011401882	pack(82046-291)

Establishment
Name	Address	ID/FEI	Business Operations
Dimensional Merchandising Inc.		076693183	pack(82046-291)